InvestorsHub Logo
Followers 116
Posts 1878
Boards Moderated 0
Alias Born 11/22/2017

Re: CaptainObvious post# 315730

Friday, 10/09/2020 6:24:08 AM

Friday, October 09, 2020 6:24:08 AM

Post# of 704499
CaptainOblivious,

Yes, LTBK-01 and LTBK-04 presentation are of similar lenght.

Plenary I
LTBK-01 - INO-5401 and INO-9012 delivered intramuscularly (IM) with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma
Friday, November 20, 2020
11:35 AM – 11:45 AM
Live Abstract Presenter(s)
David A. Reardon, M.D.
Center for Neuro-Oncology, Dana-Farber Cancer Institute


Late-Breaking
Plenary I
LTBK-04 - Phase 2 multicenter study of the oncolytic adenovirus DNX-2401 (tasadenoturev) in combination with pembrolizumab for recurrent glioblastoma; CAPTIVE Study (KEYNOTE-192)
Friday, November 20, 2020
11:45 AM – 11:55 AM
Live Abstract Presenter(s)
Gelareh Zadeh, MD, PhD
Princess Margaret Cancer Center


LTBK-03 presentation is not accepted IMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News